STOCK TITAN

ACME United (NYSE: ACU) director receives grant of 2,500 stock options at $59.90

(Moderate)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACME United Corp director Paul J. Conway reported a grant of 2,500 Employee Stock Options dated 2026-07-29. The options have an exercise price of $59.90 per share, are exercisable starting 2026-07-30, and expire on 2036-07-29. After this award, he holds 10,000 options directly.

Positive

  • None.

Negative

  • None.
Insider Conway Paul J
Role Director
Type Security Shares Price Value
Grant/Award Employee Stock Option 2,500 $59.90 $150K
Holdings After Transaction: Employee Stock Option — 10,000 shares (Direct)
Options granted 2,500 Employee Stock Options Grant to director Paul J. Conway on 2026-07-29
Exercise price $59.90 per share Exercise price of Employee Stock Option grant
Options after grant 10,000 options Total options Conway holds following the reported award
Underlying shares 2,500 shares of Common Stock Shares issuable upon exercise of the granted options
Exercise date 2026-07-30 Date from which the granted options are exercisable
Expiration date 2036-07-29 Expiration of the Employee Stock Option grant
Employee Stock Option financial
"Grant of 2,500 Employee Stock Option awards to director Paul J. Conway"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
underlying security financial
"The underlying security is ACME United Common Stock for these options"
Rule 10b5-1 trading plan financial
"The grant is not identified as made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did ACME United (ACU) director Paul J. Conway report in this Form 4?

Paul J. Conway reported a grant of 2,500 Employee Stock Options linked to ACME United common stock. The options were awarded on 2026-07-29 as equity compensation, increasing his directly held option total to 10,000.

What are the key terms of Paul J. Conway's new ACME United (ACU) stock options?

The grant covers 2,500 Employee Stock Options with an exercise price of $59.90 per share. They are exercisable from 2026-07-30, expire on 2036-07-29, and are settled in ACME United common stock on exercise.

How many ACME United (ACU) options does Paul J. Conway hold after this grant?

Following the reported grant, Paul J. Conway holds 10,000 Employee Stock Options directly. This figure reflects his total derivative holdings of options after adding the 2,500-option award disclosed in the transaction.

When can Paul J. Conway exercise his new ACME United (ACU) stock options?

The options are shown as exercisable on 2026-07-30. They carry an expiration date of 2036-07-29, providing a long-term window in which Conway may choose to exercise them, subject to applicable terms.

Was Paul J. Conway's ACME United (ACU) option grant under a Rule 10b5-1 plan?

The grant is not identified as made under a Rule 10b5-1 trading plan. The filing’s Rule 10b5-1 checkbox is not marked as a planned transaction, and there are no plan-related explanatory footnotes.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conway Paul J

(Last)(First)(Middle)
1 WATERVIEW DRIVE

(Street)
SHELTON CONNECTICUT 06484

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACME UNITED CORP [ ACU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option$59.907/29/202607/29/2026A2,50007/30/202607/29/2036Common Stock2,500$59.910,000D
Explanation of Responses:
/s/ Paul J. Conway07/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)